CEO Lishan Aklog Reports 5.1% Beneficial Ownership in PAVmed Following Significant Restricted Stock Grant
Summary
PAVmed's Chairman and CEO, Lishan Aklog, M.D., reported beneficial ownership of 5.1% of the company's common stock, primarily due to a recent grant of 350,000 restricted shares.
Key Events
-
CEO Becomes 5.1% Beneficial Owner
Dr. Lishan Aklog, Chairman and CEO, reported beneficial ownership of 369,068 shares, representing 5.1% of PAVmed's common stock.
-
Significant Restricted Stock Grant
The increase in ownership is primarily due to a grant of 350,000 restricted shares to Dr. Aklog on April 2, 2026, as compensation for services. This grant is valued at approximately $3.5 million.
-
Long-Term Vesting Schedule
These newly granted restricted shares are subject to a vesting schedule, with a single vesting date of May 20, 2029, incentivizing long-term performance.
-
No Immediate Corporate Changes Planned
The filing states that Dr. Aklog has no current plans for extraordinary corporate transactions, changes in management, or material shifts in capitalization or dividend policy.
Analysis
This Schedule 13D filing reveals that PAVmed's Chairman and CEO, Lishan Aklog, M.D., has become a 5.1% beneficial owner of the company's common stock, largely driven by a substantial grant of 350,000 restricted shares on April 2, 2026. This significant equity award, valued at approximately $3.5 million based on the current stock price, strongly aligns the CEO's long-term interests with shareholder value, especially as these shares vest over time (May 2029). The filing also confirms Dr. Aklog has no immediate plans for extraordinary corporate transactions or changes to the company's structure, providing a degree of stability. This increased insider ownership comes shortly after the company's 10-K disclosed a going concern warning and recent dilutive capital raises, suggesting a continued commitment from leadership during a critical period for the company.
At the time of this filing, PAVM was trading at $10.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $62.2M. The 52-week trading range was $6.00 to $28.44. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.